Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Management of Violent Patients with Hepatic Encephalopathy

Initial Management

  • Patients with higher grades of hepatic encephalopathy who are violent and unable to protect their airway need more intensive monitoring and should be managed in an intensive care setting 1
  • Position patients with head elevated at 30 degrees to reduce intracranial pressure 3
  • Avoid sedatives when possible as they interfere with neurological assessment and have delayed clearance in liver failure 3
  • If benzodiazepines are absolutely necessary for uncontrolled agitation or seizures, use only minimal doses due to their delayed clearance by the failing liver 3
  • Phenytoin is recommended if seizures are present in the violent patient with hepatic encephalopathy 3

Specific Pharmacological Management

  • Administer lactulose via nasogastric tube if the patient is unable to take medications orally or has an aspiration risk 1
  • For severe cases, lactulose enema can be administered: mix 300 mL of lactulose solution with 700 mL of water or physiologic saline and retain for 30-60 minutes 4
  • Add rifaximin 400 mg three times daily or 550 mg twice daily if the patient's condition does not improve with lactulose alone 4

Identify and Treat Precipitating Factors

  • Controlling precipitating factors is paramount, as nearly 90% of patients can be treated with just correction of the precipitating factor 1
  • Common precipitating factors include infections, gastrointestinal bleeding, electrolyte disturbances, medication non-compliance, and constipation 1, 2, 5

Additional Therapeutic Options

  • Consider IV L-Ornithine L-Aspartate (LOLA) 30 g/day for patients not responding to conventional therapy 4
  • Oral Branched-Chain Amino Acids (BCAAs) at 0.25 g/kg/day can be used as an alternative or additional agent for patients not responding to conventional therapy 4
  • Brain CT imaging should be performed to exclude other causes of decreased mental status and violent behavior 3

Monitoring and Follow-up

  • Educate patients and relatives about medication effects, importance of adherence, early signs of recurring hepatic encephalopathy, and actions to take if recurrence occurs 5

Pitfalls to Avoid

  • Delaying treatment while awaiting diagnostic confirmation can worsen outcomes 2
  • Overuse of lactulose can paradoxically precipitate hepatic encephalopathy and cause other complications 2
  • Failure to identify precipitating factors may lead to poor treatment response 2
  • Long-term use of antibiotics like neomycin and metronidazole should be avoided due to risks of ototoxicity, nephrotoxicity, and neurotoxicity 4